Welcome to CDC stacks | National Amyotrophic Lateral Sclerosis (ALS) Biorepository Governance : February 12, 2013 summary report - 27709 | Stephen B. Thacker CDC Library collection
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
National Amyotrophic Lateral Sclerosis (ALS) Biorepository Governance : February 12, 2013 summary report
  • Published Date:
    2013
  • Language:
    English
Filetype[PDF-516.92 KB]


Details:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. Integrating a Biorepository Into the National Amyotrophic Lateral Sclerosis Registry
    Personal Author:
    Horton, D. Kevin; Kaye, Wendy; Wagner, Laurie;
    Published:
    Nov 2016
    Source:
    J Environ Health. 79(4):38-40.
    Description:
    As part of our continuing effort to highlight innovative approaches to improving the health and environment of communities, the Journal is pleased to publish a bimonthly column from the Agency for Toxic Substances and Disease Registry (ATSDR). ATSDR ...
    File Type:
    Filetype[PDF - 129.14 KB]
  2. The National Amyotrophic Lateral Sclerosis (ALS) Registry first Biorepository pilot study expert panel meeting : March 26-27 summary report
    Corporate Author:
    United States. Agency for Toxic Substances and Disease Registry.
    Published:
    2012
    Description:
    This document has not been revised or edited to conform to agency standards. The findings and conclusions in this report are those of the meeting presenters and attendees and do not necessarily represent the views of the Agency for Toxic Substances a...
    File Type:
    Filetype[PDF - 1.01 MB]
  3. Prevalence of Amyotrophic Lateral Sclerosis — United States, 2014
    Personal Author:
    Mehta, Paul; Kaye, Wendy; Raymond, Jaime; Wu, Ruoming; Larson, Theodore; Punjani, Reshma; Heller, Daniel; Cohen, Jessica; Peters, Tracy; Muravov, Oleg; Horton, Kevin;
    Published:
    Feb 23 2018
    Source:
    MMWR Morb Mortal Wkly Rep. 67(7):216-218.
    Description:
    Amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig's disease, is a progressive and fatal neuromuscular disease; the majority of ALS patients die within 2-5 years of receiving a diagnosis (1). Familial ALS, a hereditary form of the dise...
    File Type:
    Filetype[PDF - 101.78 KB]
  4. 2016 Annual ALS Surveillance Meeting executive summary, August 3-4, 2016
    Corporate Author:
    United States. Agency for Toxic Substances and Disease Registry.
    Published:
    12/7/16
    Description:
    Due to the limited information on the unknown cause(s) of Amyotrophic Lateral Sclerosis (ALS), the Agency for Toxic Substances and Disease Registry (ATSDR) established the National ALS Registry in 2010. The primary purpose of the ALS Registry is to e...
    File Type:
    Filetype[PDF - 79.63 KB]
  5. Prevalence of amyotrophic lateral sclerosis — United States, 2012–2013
    Personal Author:
    Mehta, Paul; Kaye, Wendy; Bryan, Leah; Larson, Theodore C.; Copeland, Timothy; Wu, Jennife; Muravov, Oleg; Horton, Kevin;
    Corporate Author:
    United States. Agency for Toxic Substances and Disease Registry.
    Published:
    August 5, 2016
    Series:
    MMWR. Surveillance summaries : Morbidity and mortality weekly report. Surveillance summaries; v. 65, no. SS-8
    Description:
    Problem/Condition: Amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig’s disease, is a progressive and fatal neuromuscular disease for which no cure or viable treatment has been identified. ALS, like most noncommunicable diseases, is ...
    File Type:
    Filetype[PDF - 449.78 KB]